Teva Pharmaceuticals · 1 day ago
Senior Director Global Product Strategy Emrusolmin (GPS)
Parsippany, NJ
Full-time
Hybrid
Director/Executive
$210K/yr - $276K/yr
15+ years expTeva Pharmaceuticals is a leading manufacturer of generic medicines with a mission to make health more affordable and accessible. The Senior Director of Global Product Strategy will define the long-term strategic vision for Emrusolmin, leading the global product strategy and driving launch excellence across key markets.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Lead the development and execution of the global launch and brand strategy for Emrusolmin, including lifecycle planning and indication sequencing
Align global forecasts, target product profiles (TPPs), and clinical endpoints to ensure strategic and commercial coherence
Translate clinical and scientific data into differentiated value propositions and messaging to unlock reimbursement and drive early patient access
Provide strategic leadership for additional assets within the global neurology portfolio
Drive global launch readiness in partnership with regional commercial, medical, and affiliate teams
Identify and prioritize market expansion opportunities, including new geographies and indications
Guide lifecycle planning to optimize long-term brand value
Collaborate with R&D, Medical Affairs, Market Access, and regional teams to inform evidence generation and asset decisions
Oversee market insights, competitive intelligence, and KPI tracking to inform strategy and adapt plans
Engage KOLs, advocacy groups, and external stakeholders to shape brand perception and support scientific exchange
Own the global brand campaign and core messaging for Emrusolmin, ensuring consistency and relevance across markets
Drive storytelling excellence to communicate Emrusolmin’s value to HCPs, payers, and patients
Qualification
Required
Bachelor's degree required; Master's or other advanced degree preferred
Minimum 15 years of experience in commercial, marketing, or sales leadership, including significant people leadership
Proven success in developing strategies that deliver long-term commercial results
Launch leadership experience, including collaboration with global functions (R&D, Medical, HEOR)
Strategic thinker with deep knowledge of industry best practices and current market trends
Recognized expert with strong leadership and communication capabilities
Demonstrated success in developing others and leading high-performing teams
Operates with autonomy and accountability in a global matrix environment
Preferred
Recent experience in a Tier 1 market (US or EU5) preferred, ideally within the last 5 years
Experience across multiple therapeutic areas; neurology and/or rare diseases preferred
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time, and holiday.
Life and Disability Protection: Company paid Life and Disability insurance.
Employee Assistance Program
Employee Stock Purchase Plan
Tuition Assistance
Flexible Spending Accounts
Health Savings Account
Life Style Spending Account
Volunteer Time Off
Paid Parental Leave, if eligible
Family Building Benefits
Virtual Physical Therapy
Accident, Critical Illness and Hospital Indemnity Insurances
Identity Theft Protection
Legal Plan
Voluntary Life Insurance
Long Term Disability and more.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.01BKey Investors
Royalty PharmaBerkshire Hathaway
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
2023-02-27Post Ipo Debt· $2.25B
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-08
2025-12-25
2025-12-24
Company data provided by crunchbase